by John Conrad | Sep 12, 2024 | Policy News
In a recent hearing, the Health Care Availability & Accessibility Committee delved into the complex world of Pharmacy Benefit Managers (PBMs) and specialty pharmacies, exposing a web of concerns affecting patient care and drug pricing. The hearing, which brought...
by John Conrad | Sep 10, 2024 | iBIO News, Policy News
iBIO has joined forces with fellow members of the Council of State Bioscience Associations (CSBA) in a crucial initiative to safeguard the future of rare pediatric disease research and treatment. Yesterday, our coalition sent a letter to congressional leaders, urging...
by John Conrad | Aug 15, 2024 | Policy News
Endpoints News reported that the Biden administration has unveiled projections for the Inflation Reduction Act’s (IRA) impact on drug pricing. According to the announcement, IRA negotiations are anticipated to generate $6 billion in taxpayer savings by 2026,...
by John Conrad | Aug 14, 2024 | Policy News
In a bold move to secure Illinois’ economic future, Governor JB Pritzker has unveiled a comprehensive five-year economic growth plan that places a strong emphasis on the life sciences sector. This strategic focus aims to position Illinois at the forefront of...
by John Conrad | Aug 6, 2024 | Policy News
It has been reported that Vice President Harris has chosen Minnesota Gov. Tim Walz to be her running mate, opting for a former high school teacher and Midwestern Democrat to complete a newly assembled presidential ticket. Governor Tim Walz, with his Midwestern roots...
by John Conrad | Jul 9, 2024 | Policy News
The Federal Trade Commission (FTC) has released an interim report shedding light on the practices of pharmacy benefit managers (PBMs), the middlemen in the prescription drug supply chain. The report, part of an ongoing inquiry launched in 2022, raises significant...
